Brokerages Set Sarepta Therapeutics, Inc. (NASDAQ:SRPT) PT at $176.77
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-three research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, nineteen have given a buy recommendation and one has assigned a […]
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-three research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, nineteen have given a buy recommendation and one has assigned a […]
